DermBiont has completed enrollment in a Phase 2b clinical trial of SM-020 gel 1.0% for the treatment of seborrheic keratoses.
Denise Mann is an Editor-at-Large, Health Writer, and Editor with a wide range of experience in the field of health journalism. Her work has been featured in numerous publications, including Drugs.com, HealthDay News, and Reader's Digest. She covers a variety of topics in the health field, including dermatology, genetics, and infectious diseases.